Ohad Ilovich

Ohad Ilovich is a seasoned professional with extensive experience in clinical imaging and translational sciences. Currently serving as the Director and Head of Clinical Imaging at Amgen since October 2022, Ilovich also contributes as a reviewer for the SBIB-T/ISB-10 Study Section at the Center for Scientific Review, evaluating grant applications related to medical imaging systems. Previously, Ilovich held the position of Senior Director of Translational Sciences at Curie Therapeutics, where responsibilities included designing development pathways for novel radiopharmaceuticals. At Invicro, leadership roles spanned from Head of Scientific and Medical Services to Senior Director of Translational Research, focusing on oncology biomarker development. Earlier positions included postdoctoral research at Stanford University School of Medicine, specializing in companion diagnostics for Antibody-Drug Conjugates, and radiochemistry work at Hadassah Hospital. Ilovich's educational background includes a PhD in Molecular Imaging, an MSc in Medicinal Chemistry, and a BPharm in Pharmacy, all from The Hebrew University of Jerusalem.